Ikarian Capital »

Achilles Therapeutics shares owned by Ikarian Capital

Quarter-by-quarter ownership of Achilles Therapeutics (ACHL) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Achilles Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Achilles Therapeutics held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Achilles Therapeutics by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.5M 1.4M 1.02
2024-06-30 $1.2M 1.4M 0.82
2024-03-31 $1.8M 1.4M 1.25

More positions owned by Ikarian Capital

Vertex Pharmaceuticals Incorporated Put Option (VRTX)
Amgen Call Option (AMGN)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Tarsus Pharmaceuticals (TARS)
Beigene Sponsored Adr Call Option (BGNE)
Anaptysbio Inc Common Put Option (ANAB)
Crinetics Pharmaceuticals In (CRNX)
Celldex Therapeutics Com New Put Option (CLDX)
Soleno Therapeutics Call Option (SLNO)
Janux Therapeutics Put Option (JANX)
Biohaven Put Option (BHVN)
Miragen Therapeutics Call Option (VRDN)
Immunovant Call Option (IMVT)
Capricor Therapeutics Com New Put Option (CAPR)
Arcus Biosciences Incorporated Call Option (RCUS)

View all positions for Ikarian Capital

Top funds holding Achilles Therapeutics

Syncona Portfolio
BML Capital Management
Fcpm Iii Services B.v.
Redmile Group
Vestal Point Capital
Ikarian Capital
Siren
Renaissance Technologies
Acadian Asset Management
Two Sigma Advisers
Geode Capital Management
Two Sigma Investments
Corsair Capital Management
Baader Bank
Susquehanna International

View all funds holding Achilles Therapeutics